The opioid crisis in the United States costs tens of thousands of lives per year—and some of the victims overdose at work. Naloxone (Narcan and RiVive are two available versions) can reverse the effects of opioids and save lives, and employers are increasingly considering stocking the product at work. The FDA’s recent approval of nonprescription over-the-counter naloxone nasal sprays makes the life-saving drug more accessible to employers that want to have them on hand in case of an emergency. This multistate webinar will focus on individual state laws and requirements as well as address frequently asked questions and best practices for large and small employers alike.

Our I-9 compliance webinar series is designed for attorneys and HR professionals who are new to the employment eligibility verification process, or who simply want to review the basics. In the third installment of the series, the speakers will cover the standard process for audits and investigations conducted by Homeland Security Investigations (HSI), the investigative arm of the U.S. Department of Homeland Security. The speakers will also discuss the civil fines matrix and offer practical tips for responding to these enforcement mechanisms.